Skip to main content
. 2022 Sep 29;62(5):1877–1886. doi: 10.1093/rheumatology/keac557

Table 2.

Profiles assessed by dimension

Severity
Risk of progression
Progression
Number of profiles assessed 80 80 40
Profiles achieving consensus, n (%)a 60 (75) 57 (71) 24 (60)
 Subset Subclinical 3 High Risk 26 Improved 3
Clinical 55 Low Risk 31 Progressive 4
Stable 17
 Cannot classify (based on the given information) 2 0 0
Profiles not achieving consensus, n (%) 20 (25) 23 (29) 16 (40)
a

A consensus was reached if ≥75% of experts in each group agreed.